Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery ...

The SIRONA trial aimed to determine whether sirolimus-coated balloons could provide comparable safety and efficacy outcomes ...

Actively engaged with Terumo in Virtue SAB partnership restructuring discussions.

Philips has now developed a device intended to integrate two forms of laser-based PAD therapy, atherectomy and intravascular ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Diabetes silently affects millions globally, often progressing without obvious symptoms until it creates life-altering complications. Among the most s ...

These included age, sex, smoking status, hypertension status, Type 2 diabetes status, peripheral artery disease, hyperlipidemia, chronic kidney disease and a history of heart attack or a history of ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

DURHAM, N.C., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...